Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
AAL-993 in Angiogenesis Assay Design
2026-09-04
AAL-993 is a selective VEGF receptor inhibitor for dissecting VEGFR-driven angiogenesis, tumor growth, and metastasis. This article connects its kinase profile with pathway-aware assay design inspired by recent glioma network pharmacology research, while clearly separating established evidence from testable hypotheses.
-
Brain-to-Spinal Control of Mechanical Allodynia
2026-09-04
Huo et al. identify a contralateral lPBN Oprm1–dmH Pdyn–spinal dorsal horn pathway that limits both the spread and persistence of mechanical allodynia in mice. The study separates neural control of pain laterality from pain duration and provides a circuit-level framework for interpreting bilateral hypersensitivity after injury.
-
Naftifine HCl: Mechanism-to-Assay Strategy
2026-09-03
Naftifine HCl is an allylamine antifungal agent whose value in research extends beyond simple growth inhibition. This mechanism-aware guide connects sterol biology, orthogonal assay design, and lessons from a WNT5a/GSK3/β-catenin study to improve interpretation of dermatophyte experiments.
-
Reversine: From Mitotic Stress to Translation
2026-09-03
Reversine offers translational researchers a practical way to interrogate Aurora kinase signaling, mitotic checkpoint control, cancer cell proliferation inhibition, and apoptosis induction in cancer cells. This thought-leadership perspective connects its mechanistic value with emerging single-structure screening platforms while clearly separating established evidence from forward-looking applications.
-
Cyclic Pifithrin-α Hydrobromide in Neuroinflammation
2026-09-02
Cyclic Pifithrin-α hydrobromide is a research-grade p53 inhibitor that can help separate p53-dependent stress transcription from calcium-driven neuroinflammatory signaling. This article develops an assay strategy connecting p53 perturbation with the CGRP/SP–Piezo2 axis while clearly distinguishing established evidence from exploratory applications.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-09-02
Translate WST-1 color development into a practical readout of superoxide dismutase activity in biological fluids, with a workflow suited to oxidative stress studies and plate-based screening. The guide also shows when this SOD Activity Assay is preferable to, or should be paired with, hydrogen peroxide measurements that may be vulnerable to carboxylesterase interference.
-
L-Phenylephrine in Sex-Aware Cardiovascular Assays
2026-09-01
Build more interpretable adrenergic assays with L-Phenylephrine, from telemetry-based baroreflex studies to cardiomyocyte and neural progenitor workflows. This guide combines sex-aware experimental design, receptor-focused controls, practical dosing ranges, and troubleshooting strategies for research use only.
-
MitMAB for Mechanistic Organoid Uptake Studies
2026-09-01
MitMAB enables mechanistic analysis of dynamin-dependent uptake in physiologically relevant intestinal organoids. This article translates milk-derived extracellular vesicle findings into a rigorous assay framework that separates epithelial polarity, vesicle internalization, and membrane-scission effects.
-
Calcium Kinetics for Smarter AF Biomaterials
2026-08-31
Fiber density can steer annulus fibrosus cell phenotype, but calcium kinetics may reveal mechanotransductive decisions before collagen endpoints emerge. This thought-leadership guide shows how the Fluo-4 AM Calcium Assay Kit can help translational researchers connect scaffold architecture, intracellular calcium detection, and scalable screening strategy.
-
Toremifene for Reliable Cell Growth Assays
2026-08-31
Learn how Toremifene (SKU A3884) can support reproducible cell viability, proliferation, and cytotoxicity workflows in hormone-responsive cancer models. This scenario-based guide connects dose-response design, solvent control, assay optimization, and cautious interpretation with current prostate cancer biology.
-
Lysosomal β-Galactosidase Staining Kit in Senescence
2026-08-30
Use the Lysosomal β-Galactosidase Staining Kit as a chromogenic lysosomal activity control—not as a stand-alone proof of senescence. This guide translates recent HNSCC cisplatin-resistance findings into practical plate, tissue-section, imaging, and troubleshooting workflows.
-
APEX2 Control of TERT Expression in Human Stem Cells
2026-08-29
A 2024 preprint identifies APEX2 as a DNA repair factor required for efficient TERT expression in human embryonic stem cells and a melanoma model, distinguishing it from the related enzyme APEX1. Its RNA-seq and chromatin-binding data suggest that APEX2 may support transcription through repair of damage-prone repetitive elements within the TERT locus.
-
6-FAM SE: Reliable Fluorescent Labeling
2026-08-28
Learn how 6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester), SKU A8771, can improve amine-directed labeling workflows used alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers compatibility, handling, data interpretation, and evidence-based product selection.
-
CDK4/6–BET Synergy Reverses PDAC EMT
2026-08-28
Gu et al. show that combining CDK4/6 inhibition with BET inhibition can address a key limitation of cell-cycle blockade in pancreatic ductal adenocarcinoma: reduced proliferation may coexist with enhanced migration, invasion, and epithelial-to-mesenchymal transition. The reference study connects this response to GSK3β-mediated Wnt/β-catenin signaling and supports dual-pathway treatment in cellular and orthotopic models.
-
Pyridostatin: From G-Quadruplexes to Translation
2026-08-27
Pyridostatin TFA offers translational researchers a mechanistic probe for connecting G-quadruplex stabilization with telomere dysfunction, selective cancer-cell responses, and emerging RNA-structure biology. This article outlines how to move beyond viability assays toward structure-aware validation while defining the opportunities and limitations of extending DNA G-quadruplex findings into TDP-43 and neurodegeneration models.